BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota
BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota
Westport, CT, Dec. 18, 2020 — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company and its NeuroClear Technologies division signed a new research agreement with the University of Minnesota. 
Under the terms of the agreement, the Company intends to launch a program to develop novel therapies to treat sympathetic nervous system disease. Due to launch in Q4 2020, the program studies are expected to form a foundation for developing a new platform technology to address disorders of the autonomic nervous system. NeuroClear intends to develop new intellectual properties and products, including new hardware, software, and algorithmic solutions, with the support of a tier 1 US-based manufacturing partner and take it through FDA approval, manufacturing, and commercialization. The R&D program will be run under the leadership of Richard W. Bianco, Ph.D., Professor, Director of Experimental Surgical Services (ESS), Department of Surgery in the University of Minnesota Medical School, John W. Osborn, Ph.D., Professor, Department of Surgery and Director of the Minnesota Consortium for Autonomic Neuromodulation (MCAN) in the University of Minnesota Medical School and Barry Keenan, Ph.D., Vice President of Engineering at NeuroClear.

Related Keywords

Barry Keenan , Johnw Osborn , Richardw Bianco , Biosig Technologies Inc , Engineering Of Biosig Technologies Inc , Minnesota Consortium For Autonomic Neuromodulation , Andrew Ballou Biosig Technologies Inc , Experimental Surgical Services , Department Of Surgery , Nasdaq , Company Annual Report On Form , Exchange Commission , University Of Minnesota Medical School , University Of Minnesota , Biosig Technologies , Neuroclear Technologies , Minnesota Medical School , Minnesota Consortium , Autonomic Neuromodulation , Vice President , Kennethl Londoner , Neuroclear Technologies Founded , Annual Report , Quarterly Reports , பாரி கீநெந் , சோதனை அறுவை சிகிச்சை சேவைகள் , துறை ஆஃப் அறுவை சிகிச்சை , நாஸ்டாக் , நிறுவனம் ஆண்டு அறிக்கை ஆன் வடிவம் , பரிமாற்றம் தரகு , பல்கலைக்கழகம் ஆஃப் மினசோட்டா மருத்துவ பள்ளி , பல்கலைக்கழகம் ஆஃப் மினசோட்டா , மினசோட்டா மருத்துவ பள்ளி , மினசோட்டா கூட்டமைப்பு , துணை ப்ரெஸிடெஂட் , ஆண்டு அறிக்கை , காலாண்டு அறிக்கைகள் ,